Literature DB >> 3254636

Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex.

P J Lindholm-Levy1, L B Heifets.   

Abstract

Clofazimine (Lamprene, B663) and 11 rimino-compounds were tested for activity against Mycobacterium avium by finding the minimal inhibitory concentrations (MIC) of these drugs in liquid medium. The activity of these compounds was affected in acidic conditions (pH 6.0 and 5.0), but the MICs observed even at pH 5.0 were significantly lower than the concentrations achievable in macrophages. This information is especially useful in the light of four important facts: that these drugs tend to accumulate within macrophages; that M. avium tends to multiply within macrophages; that this intracellular environment has a low pH; and that M. avium tolerates these low pH conditions. Such data confirm the expectation that rimino-compounds inhibit the intracellular M. avium bacterial population. The minimal bactericidal concentrations (MBC) of clofazimine and B746, the most active analogue, were from 64 to 256 times higher than the MIC, but it is not clear whether these drugs can accumulate within the macrophages in concentrations high enough to produce the bactericidal effect as well.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3254636     DOI: 10.1016/0041-3879(88)90019-0

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  8 in total

1.  Use of thalidomide in leprosy.

Authors:  M Hooper
Journal:  BMJ       Date:  1991-11-30

2.  MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.

Authors:  L B Heifets; P J Lindholm-Levy
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages.

Authors:  N Mor; L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

4.  In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis.

Authors:  R T Mehta; A Keyhani; T J McQueen; B Rosenbaum; K V Rolston; J J Tarrand
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

5.  Antituberculosis activities of clofazimine and its new analogs B4154 and B4157.

Authors:  V M Reddy; G Nadadhur; D Daneluzzi; J F O'Sullivan; P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 6.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 7.  Drug treatment of tuberculosis--1992.

Authors:  P T Davidson; H Q Le
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

Review 8.  Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.

Authors:  Mpelegeng Victoria Bvumbi
Journal:  ChemMedChem       Date:  2020-10-15       Impact factor: 3.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.